Long-Term Follow-Up Safety and Effectiveness of CT-Guided Radiofrequency Thermocoagulation of Sphenopalatine Ganglion in Refractory Headache Treatment - Pain and Therapy
Source : https://link.springer.com/article/10.1007/s40122-022-00401-0
Objective The purpose of this study was to evaluate the effectiveness and safety of computed tomography (CT)-guided radiofrequency thermocoagulation (RFTA) of the sphenopalatine ganglion (SPG) for patients with refractory headache.
Conclusion: CT-guided RFTA of the SPG significantly relieves headache symptoms in patients with refractory migraine and CH. It has the advantages of rapid onset, long duration, and a safe and reliable treatment process, making it worthy of clinical application.
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrImportant research!
Nutraceuticals and migraine: further strategy for the treatment of specific conditions - Neurological Sciences
Source : https://link.springer.com/article/10.1007/s10072-022-06250-1
Nutraceuticals might be defined as food or dietary supplements that provide medicinal or health benefits. Current preventive treatment of migraine includes nutraceuticals as well as conventional drugs.
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrTHere is now more and more evidence for these now.
The importance of an early onset of migraine prevention: an evidence-based, hypothesis-driven scoping literature review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35662957/
Recently approved migraine preventive therapies facilitate rapid control of migraine activity, potentially improving patients' lives and minimizing the societal burden of migraine. This review synthesizes available evidence on rates and...
Relevance: Recently approved migraine preventive therapies facilitate rapid control of migraine activity, potentially improving patients' lives and minimizing the societal burden of migraine. This review synthesizes available evidence on rates and timing of early onset of migraine prevention and identifies patient-level outcomes related to...
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrEarly diagnosis and treatment of migraine is so essential.
-
Migraine Connect4yrKey Points • Source: Therapeutic Advances in Neurological Disorders • Conclusion: “No evidence was identified in any publication to support the null hypothesis that patients with migraine do not benefit from an early onset Show More
Patient characteristics and treatment utilization among patients with migraine initiating self-injectable calcitonin gene-related peptide monoclonal antibody and novel acute medication
Source : https://www.tandfonline.com/doi/abs/10.1080/03007995.2022.2091333?journalCode=icmo20
Abstract This study described patient characteristics and utilization of recently approved novel acute medication and calcitonin gene-related peptide (CGRP) monoclonal antibodies. This retrospective observational study utilized the IBM MarketScan Research...
Conclusions: Understanding patient characteristics and treatment utilization patterns among patients prescribed both a CGRP mAb and novel acute medication may provide valuable insight regarding migraine treatment selection for healthcare decision makers.
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrThis should be available to everyone.
Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35727536/
doi: 10.1007/s40261-022-01171-5. Online ahead of print. 1 Clinical Trial Center/NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital of Sichuan University, No.5 Telecom Road, Wuhou...
Conclusions: Erenumab was safe and well tolerated after a single subcutaneous injection in healthy Chinese subjects. The systemic exposure in Chinese subjects in terms of AUC0-∞ was 70% higher than that in White subjects as previously reported.
-
Huma Sheikh, CEO, NY Neurology Medicine, PC4yrThis is good real world data.